Kangyuan Pharmaceuticals: Clinical trials of black, yellow, and red bead granules approved.

Kangyuan Pharmaceutical Company announced that it recently received the "Notice of Drug Clinical Trial Approval" for the Black and Yellowish Red Pearl Granules issued by the National Medical Products Administration. The drug name is Black and Yellowish Red Pearl Granules, indicated for chronic heart failure, classified as Traditional Chinese Medicine Innovative Drug Class 1.1, and the dosage form is granules. The clinical trial application submitted by the applicant Jiangsu Kangyuan Pharmaceutical Co., Ltd meets the relevant requirements for drug registration, and it is approved to conduct clinical trials for chronic heart failure.